Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.570
EU - Europa 3.449
AS - Asia 1.524
SA - Sud America 154
AF - Africa 25
OC - Oceania 2
Totale 9.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.533
IT - Italia 958
SG - Singapore 726
RU - Federazione Russa 609
DE - Germania 591
SE - Svezia 446
IE - Irlanda 334
HK - Hong Kong 332
CN - Cina 227
GB - Regno Unito 180
BR - Brasile 133
ID - Indonesia 75
NL - Olanda 56
AT - Austria 47
FI - Finlandia 44
IN - India 42
FR - Francia 38
UA - Ucraina 29
CA - Canada 26
VN - Vietnam 24
BE - Belgio 20
MY - Malesia 20
DK - Danimarca 17
TR - Turchia 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 10
IL - Israele 10
ES - Italia 9
LT - Lituania 8
PL - Polonia 8
SK - Slovacchia (Repubblica Slovacca) 8
IR - Iran 7
AR - Argentina 6
CH - Svizzera 6
GR - Grecia 6
IQ - Iraq 6
PK - Pakistan 6
PT - Portogallo 6
MX - Messico 5
TW - Taiwan 5
EC - Ecuador 4
EG - Egitto 4
JP - Giappone 4
MM - Myanmar 4
RO - Romania 4
RS - Serbia 4
BO - Bolivia 3
KR - Corea 3
NO - Norvegia 3
SC - Seychelles 3
AZ - Azerbaigian 2
BD - Bangladesh 2
CO - Colombia 2
GH - Ghana 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.724
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.272
Singapore 498
Frankfurt am Main 474
Fairfield 361
Milan 352
Hong Kong 325
Dublin 318
Chandler 292
Wilmington 265
Ashburn 207
Santa Clara 187
Woodbridge 166
New York 145
Seattle 133
Houston 129
Cambridge 118
Chicago 100
London 99
Princeton 98
Jakarta 72
Shanghai 72
Dearborn 66
Altamura 46
Lawrence 46
Rome 45
Helsinki 35
Boardman 34
Moscow 32
Los Angeles 26
San Diego 26
Vienna 26
Nuremberg 25
Beijing 23
Monza 23
Florence 21
Pune 20
Brussels 19
Jacksonville 19
Council Bluffs 17
Munich 17
Penang 16
Guangzhou 15
São Paulo 15
Toronto 14
Bari 13
Nanjing 13
Turin 13
Mumbai 11
Andover 10
Lissone 10
Bologna 9
Brno 9
Fremont 9
Lappeenranta 9
Naples 9
Padova 9
Seregno 9
Dong Ket 8
Amsterdam 7
Cagliari 7
Dongguan 7
Hangzhou 7
Modena 7
Bergamo 6
Bratislava 6
Central 6
Dallas 6
Jinan 6
Kocaeli 6
Paris 6
Rio de Janeiro 6
Rovereto 6
Somma Vesuviana 6
Udine 6
Belo Horizonte 5
Campinas 5
Carate Brianza 5
Delmar 5
Desio 5
Düsseldorf 5
Genoa 5
Huizen 5
Lauterbourg 5
Lisbon 5
Marietta 5
Sacramento 5
Shenyang 5
Washington 5
Appiano Gentile 4
Athens 4
Atlanta 4
Brescia 4
Castiglione del Lago 4
Changsha 4
Hebei 4
Hefei 4
Kruševac 4
Meda 4
Norwalk 4
Quanzhou 4
Totale 6.669
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 439
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 265
Better end points needed in primary sclerosing cholangitis trials 228
A second update on mapping the human genetic architecture of COVID-19 218
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 217
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 206
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 204
Mapping the human genetic architecture of COVID-19 202
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 200
Precision medicine in primary biliary cholangitis 199
Risk stratification in primary sclerosing cholangitis 198
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 189
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 187
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 184
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 184
New Therapeutic Targets in Autoimmune Cholangiopathies 177
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 176
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 174
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 174
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 173
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 173
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 171
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 170
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 161
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 160
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 159
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 159
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 148
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 142
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 141
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 140
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 138
The immunobiology of female predominance in primary biliary cholangitis 131
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 124
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 124
Gender differences in liver disease and the drug-dose gender gap 118
The application of artificial intelligence in hepatology: A systematic review 118
Cost of illness of Primary Biliary Cholangitis - a population-based study 115
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 109
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 104
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 102
Artificial Intelligence and liver: Opportunities and barriers 101
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 101
The role of ethnicity in autoimmune hepatitis 100
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 98
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 98
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 91
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 91
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 91
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 91
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 90
Artificial intelligence for precision medicine in autoimmune liver disease 86
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 85
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 80
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 79
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 71
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 71
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 67
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 66
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 66
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 62
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 61
X marks the spot in autoimmunity 60
The Role of Epigenetics in Primary Biliary Cholangitis 58
GWAS and autoimmunity: What have we learned and what next 57
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 56
Genetics of Primary Biliary Cholangitis 53
Open challenges in the management of autoimmune hepatitis 52
Bacterascites confers poor patient prognosis beyond MELD prediction 51
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 49
The genetic architecture of primary biliary cholangitis 45
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 45
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 42
Primary Sclerosing Cholangitis 39
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 37
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 36
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 34
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 33
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 32
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 32
Genetics of Autoimmune Liver Diseases 32
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 31
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 30
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 29
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 29
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 26
Incomplete normalization of transaminases at 18 months is the most important predictor for failure of biochemical response in autoimmune hepatitis 26
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 25
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 25
The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe 20
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 19
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 19
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 19
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 19
Primary Biliary Cholangitis 18
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 18
Cost of Illness of Primary Biliary Cholangitis in Lombardia 16
Totale 10.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 0 0 0 0 0 0 0 0 0 92 52 23
2020/20211.525 34 29 276 66 122 205 170 223 102 85 119 94
2021/20221.051 107 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/20252.995 254 400 218 187 325 197 247 209 426 532 0 0
Totale 10.232